mRNA Vaccines for the Win; But mRNA Therapies…?
Elie Dolgin • November 24, 2021
Unclear road ahead for biotech behind COVID-19 immunization successes
Continue reading at IEEE Spectrum.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.